Previous studies demonstrated that it could enact these functions through participating in the programmed death ligand-1/integrin β/activator of the transcription 3 (PD-L1/ITGB6/STAT3) signaling pathway in bladder cancer [45]. This evidence concerns the gene STAT3 and urinary bladder cancer.